Climb Bio Inc (CLYM)

$3.00 +0.70 (30.43%)
Market Cap 141.82M
Revenue (ttm) 0.00
Net Income (ttm) -73.90M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 8,369,400
Avg Vol 667,532
Day's Range N/A - N/A
Shares Out 68.18M
Stochastic %K 99%
Beta -0.06
Analysts Strong Sell
Price Target $9.20

Company Profile

Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies for immune-mediated diseases. The company develops budoprutug, an anti-CD19 monoclonal antibody for the treatment of B-cell mediated diseases. It is also developing budoprutug IV for the treatment of primary membranous nephropathy, immune thrombocytopenia, and systemic lupus erythematosus. In addition, the company is developing CLYM116, a preclinical stage anti A Proliferation-inducing Ligand (APRIL) monoclo...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 857 2596
Address:
20 William Street, Suite 145, Wellesley Hills, United States
MrGunnaWave
MrGunnaWave Dec. 12 at 11:30 PM
Micro float ARBB is getting a lot of attention! Could be the next crazy runner! EVERY small float ticker is running 200-400% lately! ARBB trending on Stocktwits! Starting to get found. Only 500k shares outstanding - It's breaking out! Swings: $HYFM $BMGL $CLYM $MKZR ***
0 · Reply
MooonSwinger
MooonSwinger Dec. 12 at 10:30 PM
$WFC $SVRE $CLYM $CSIQ $STRL is
0 · Reply
RunnerSignals
RunnerSignals Dec. 12 at 9:51 PM
Who is riding today big movers $YCBD $CGC $TLRY $CLYM $FEIM are lighting up the charts https://stocksrunner.com/news/2025-12-12-top-movers-and-shakers-today
0 · Reply
dbr_island
dbr_island Dec. 12 at 7:54 PM
$UGRO BOOM SHAKALA!!!!! 🚨TOVX🚨smart money getting in while it’s not found $RYM $THH $CLYM $MSOS what a day
0 · Reply
Amitzohar
Amitzohar Dec. 12 at 7:53 PM
$CLYM “Do you think the stock will correct downward in the near future?”
1 · Reply
LarastockCroft
LarastockCroft Dec. 12 at 6:24 PM
The chinese mafia is squeezing LGHL next!! Look at LGHL exploding off the OCG run!! Can LGHL run 200% aswell?! The chinese operator moved to LGHL now!! $TLRY $CLYM $GRWG $AKAN $NCPL moved to LGHL
0 · Reply
topstockalerts
topstockalerts Dec. 12 at 6:06 PM
Top Gainers PT2 $CGC $BMGL $RVNL $CLYM $NCI
0 · Reply
Geraldgenofranco75
Geraldgenofranco75 Dec. 12 at 5:52 PM
$CLYM $KYTX Amazing calls Jack.
0 · Reply
John_week
John_week Dec. 12 at 5:43 PM
$CLYM we ll break 3.20 after lunch
0 · Reply
topstockalerts
topstockalerts Dec. 12 at 5:37 PM
$CLYM sector heating up.. stay tuned!
0 · Reply
Latest News on CLYM
Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Nov 25, 2025, 7:00 AM EST - 17 days ago

Climb Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Nov 6, 2025, 7:01 AM EST - 5 weeks ago

Climb Bio Reports Third Quarter 2025 Financial Results and Provides Business Updates

Climb Bio to Present at Upcoming Investor Conferences

Nov 3, 2025, 7:00 AM EST - 5 weeks ago

Climb Bio to Present at Upcoming Investor Conferences

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy

Oct 21, 2025, 7:00 AM EDT - 7 weeks ago

Climb Bio Names Adam Villa as SVP, Technical Operations and Ashley Jones as SVP, People & Workforce Strategy

Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025

Oct 17, 2025, 7:00 AM EDT - 2 months ago

Climb Bio to Present Data at American Society of Nephrology (ASN) Kidney Week 2025

Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer

Oct 1, 2025, 7:00 AM EDT - 2 months ago

Climb Bio Appoints Susan Altschuller, Ph.D., MBA as Chief Financial Officer

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN

Sep 29, 2025, 7:00 AM EDT - 2 months ago

Climb Bio Announces CLYM116 Preclinical Data Highlighting Potential for Best-In-Class Therapeutic for IgAN

Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025

Sep 4, 2025, 7:00 AM EDT - 3 months ago

Climb Bio to Host Webcast Highlighting CLYM116 and the IgA Nephropathy (IgAN) Opportunity on September 29, 2025

UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences

Aug 25, 2025, 2:41 PM EDT - 3 months ago

UPDATE – Climb Bio to Present at Upcoming September 2025 Investor Conferences

Climb Bio to Present at Upcoming September 2025 Investor Conferences

Aug 25, 2025, 7:00 AM EDT - 3 months ago

Climb Bio to Present at Upcoming September 2025 Investor Conferences

Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Aug 12, 2025, 7:00 AM EDT - 4 months ago

Climb Bio Reports Second Quarter 2025 Financial Results and Provides Business Updates

Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

May 14, 2025, 7:00 AM EDT - 7 months ago

Climb Bio Reports First Quarter 2025 Financial Results and Provides Business Updates

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Apr 1, 2025, 7:00 AM EDT - 9 months ago

Climb Bio Appoints Seasoned Biotech Leaders to Board of Directors

Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference

Mar 27, 2025, 7:00 AM EDT - 9 months ago

Climb Bio to Present at the 24th Annual Needham Virtual Healthcare Conference

Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates

Mar 25, 2025, 4:05 PM EDT - 9 months ago

Climb Bio Reports Fourth Quarter and Year-End 2024 Financial Results and Provides Business Updates

Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer

Feb 24, 2025, 7:00 AM EST - 10 months ago

Climb Bio Appoints Perrin Wilson, Ph.D., as Chief Business Officer

Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Feb 4, 2025, 7:00 AM EST - 11 months ago

Climb Bio to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Jan 9, 2025, 7:00 AM EST - 1 year ago

Climb Bio Expands Pipeline Through an Exclusive License to Develop and Commercialize an Antibody Targeting the APRIL Pathway for IgA Nephropathy

Climb Bio to be Added to the Nasdaq Biotechnology Index

Dec 19, 2024, 7:00 AM EST - 1 year ago

Climb Bio to be Added to the Nasdaq Biotechnology Index

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Nov 12, 2024, 4:05 PM EST - 1 year ago

Climb Bio Reports Third Quarter 2024 Financial Results and Business Highlights

Climb Bio Appoints Douglas E. Williams, Ph.D.

Nov 11, 2024, 7:00 AM EST - 1 year ago

Climb Bio Appoints Douglas E. Williams, Ph.D.

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Oct 15, 2024, 7:00 AM EDT - 1 year ago

Climb Bio to Provide Budoprutug Development Strategy and Corporate Update at Virtual Investor Event

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Oct 11, 2024, 12:30 PM EDT - 1 year ago

Climb Bio Announces Abstract Selected for Presentation at the American Society of Nephrology Kidney Week 2024

Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Oct 4, 2024, 7:00 AM EDT - 1 year ago

Climb Bio to Present at William Blair's Upcoming Conference Event on Transforming Autoimmune Diseases by Targeting CD19

Climb Bio to Host Virtual Investor Event on October 15, 2024

Oct 3, 2024, 10:00 AM EDT - 1 year ago

Climb Bio to Host Virtual Investor Event on October 15, 2024

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

Oct 2, 2024, 9:00 AM EDT - 1 year ago

Eliem Therapeutics Announces Rebranding and Corporate Name Change to Climb Bio, Inc.

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

Sep 11, 2024, 7:00 AM EDT - 1 year ago

Eliem Therapeutics to Participate at the Stifel 2024 Virtual Immunology and Inflammation Summit

Eliem Therapeutics Announces Additions to its Leadership Team

Aug 26, 2024, 7:00 AM EDT - 1 year ago

Eliem Therapeutics Announces Additions to its Leadership Team

Eliem Therapeutics Reports Second Quarter Financial Results

Aug 14, 2024, 6:05 AM EDT - 1 year ago

Eliem Therapeutics Reports Second Quarter Financial Results

Eliem Therapeutics: Year End 2024 MN Data With Further Potential To Unlock Value

Jun 28, 2024, 1:58 PM EDT - 1 year ago

Eliem Therapeutics: Year End 2024 MN Data With Further Potential To Unlock Value

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes

Jun 28, 2024, 7:00 AM EDT - 1 year ago

Eliem Therapeutics Announces its Addition to the Russell 2000® and Russell 3000® Indexes

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Jun 27, 2024, 4:01 PM EDT - 1 year ago

Eliem Therapeutics Announces the Closing of its Acquisition of Tenet Medicines and Concurrent $120 Million Private Placement

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Apr 11, 2024, 7:00 AM EDT - 1 year ago

Eliem Therapeutics Announces Agreement to Acquire Tenet Medicines and Concurrent $120 Million Private Placement

Eliem Therapeutics' stock soars 21% premarket after company says it may sell itself

Jul 20, 2023, 6:57 AM EDT - 2 years ago

Eliem Therapeutics' stock soars 21% premarket after company says it may sell itself

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

Jul 20, 2023, 6:45 AM EDT - 2 years ago

Eliem Therapeutics Announces Plans to Explore Strategic Alternatives

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

May 11, 2023, 4:10 PM EDT - 2 years ago

Eliem Therapeutics Reports First Quarter Financial Results and Business Highlights

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

Mar 6, 2023, 4:10 PM EST - 3 years ago

Eliem Therapeutics Reports Fourth Quarter and Year-End Financial Results and Business Highlights

Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition

Feb 9, 2023, 4:01 PM EST - 3 years ago

Eliem Therapeutics Provides Strategic Update and Announces Leadership Transition

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

Nov 30, 2022, 7:00 AM EST - 3 years ago

Eliem Therapeutics at the 5th Annual Evercore ISI HealthCONx Virtual Conference

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

Nov 14, 2022, 6:10 AM EST - 3 years ago

Eliem Therapeutics Reports Third Quarter Financial and Business Highlights

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

Nov 8, 2022, 7:00 AM EST - 3 years ago

Eliem Therapeutics to Participate at Two Upcoming Investor Conferences

Eliem Therapeutics Provides Update on Pipeline Progress

Oct 5, 2022, 7:00 AM EDT - 3 years ago

Eliem Therapeutics Provides Update on Pipeline Progress

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

Aug 15, 2022, 6:10 AM EDT - 3 years ago

Eliem Therapeutics Reports Second Quarter Financial and Business Highlights

Eliem's stock slides 20% after saying it will discontinue development of pain treatment

Aug 2, 2022, 9:33 AM EDT - 3 years ago

Eliem's stock slides 20% after saying it will discontinue development of pain treatment

Eliem Therapeutics Provides ETX-810 Program Update

Aug 2, 2022, 7:00 AM EDT - 3 years ago

Eliem Therapeutics Provides ETX-810 Program Update

Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder

Jul 18, 2022, 7:00 AM EDT - 3 years ago

Eliem Announces Updated Development Plans and the Advancement of ETX-155 for the Treatment of Major Depressive Disorder

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

Jul 7, 2022, 7:00 AM EDT - 3 years ago

Eliem Therapeutics to Host Virtual Investor Event on July 21, 2022

MrGunnaWave
MrGunnaWave Dec. 12 at 11:30 PM
Micro float ARBB is getting a lot of attention! Could be the next crazy runner! EVERY small float ticker is running 200-400% lately! ARBB trending on Stocktwits! Starting to get found. Only 500k shares outstanding - It's breaking out! Swings: $HYFM $BMGL $CLYM $MKZR ***
0 · Reply
MooonSwinger
MooonSwinger Dec. 12 at 10:30 PM
$WFC $SVRE $CLYM $CSIQ $STRL is
0 · Reply
RunnerSignals
RunnerSignals Dec. 12 at 9:51 PM
Who is riding today big movers $YCBD $CGC $TLRY $CLYM $FEIM are lighting up the charts https://stocksrunner.com/news/2025-12-12-top-movers-and-shakers-today
0 · Reply
dbr_island
dbr_island Dec. 12 at 7:54 PM
$UGRO BOOM SHAKALA!!!!! 🚨TOVX🚨smart money getting in while it’s not found $RYM $THH $CLYM $MSOS what a day
0 · Reply
Amitzohar
Amitzohar Dec. 12 at 7:53 PM
$CLYM “Do you think the stock will correct downward in the near future?”
1 · Reply
LarastockCroft
LarastockCroft Dec. 12 at 6:24 PM
The chinese mafia is squeezing LGHL next!! Look at LGHL exploding off the OCG run!! Can LGHL run 200% aswell?! The chinese operator moved to LGHL now!! $TLRY $CLYM $GRWG $AKAN $NCPL moved to LGHL
0 · Reply
topstockalerts
topstockalerts Dec. 12 at 6:06 PM
Top Gainers PT2 $CGC $BMGL $RVNL $CLYM $NCI
0 · Reply
Geraldgenofranco75
Geraldgenofranco75 Dec. 12 at 5:52 PM
$CLYM $KYTX Amazing calls Jack.
0 · Reply
John_week
John_week Dec. 12 at 5:43 PM
$CLYM we ll break 3.20 after lunch
0 · Reply
topstockalerts
topstockalerts Dec. 12 at 5:37 PM
$CLYM sector heating up.. stay tuned!
0 · Reply
Mrityun21
Mrityun21 Dec. 12 at 5:13 PM
$CLYM added
0 · Reply
IBOTTheDipAndTheDipWon
IBOTTheDipAndTheDipWon Dec. 12 at 5:12 PM
$CLYM Wen no parenthesis on the income statement?
0 · Reply
jacksparo
jacksparo Dec. 12 at 5:08 PM
$CLYM $KYTX They can say whatever they want! In my record book! Too many successful trades this week alone! Stay tuned my email team for the Christmas gift list from Jack it is coming very soon ✅✅📈✅✅📈!
0 · Reply
AOB1992
AOB1992 Dec. 12 at 4:36 PM
$CLYM back to back green breakouts 👀
0 · Reply
McKenna14
McKenna14 Dec. 12 at 4:31 PM
$CLYM what is going on Here ? Looks very strong
0 · Reply
SpinnerInvestingTrust
SpinnerInvestingTrust Dec. 12 at 4:20 PM
$CLYM news or what?
0 · Reply
John_week
John_week Dec. 12 at 4:17 PM
$CLYM
0 · Reply
BiotechBonesaw
BiotechBonesaw Dec. 12 at 4:11 PM
$CLYM keep climbing 🧗
0 · Reply
therealcryptocowboy
therealcryptocowboy Dec. 12 at 3:38 PM
$CLYM amazing, great volume coming in🔥🔥🔥
0 · Reply
jacksparo
jacksparo Dec. 12 at 3:28 PM
$CLYM Last Thursday email. From that day till today 30% Another mover !!
0 · Reply
therealcryptocowboy
therealcryptocowboy Dec. 12 at 2:44 AM
$CLYM 🥰👊🔥
0 · Reply
therealcryptocowboy
therealcryptocowboy Dec. 11 at 9:23 PM
$CLYM another great day!!!
0 · Reply